Nureca Limited has informed the stock exchanges regarding a hearing notice received from the Directorate of Revenue Intelligence (DRI). The notice pertained to a matter concerning product classification under Section 108 of the Customs Act, 1962.

The company reported that the hearing was conducted on May 13, 2026. Nureca duly attended the proceedings and represented its case before the concerned authority during the session.

Following the hearing, the company made a pre-deposit amounting to INR 57,12,811. This payment was made pursuant to the ongoing proceedings and in accordance with applicable legal requirements. The company explicitly stated that the deposit was made without prejudice to its rights and contentions and does not constitute any admission of liability.

As of the date of the intimation, no formal order has been issued by the DRI regarding the matter. Nureca confirmed that it will keep the stock exchanges informed regarding any further material developments, including the receipt or finalization of any order, as and when required.

Nureca Limited has submitted its quarterly regulatory certificate to both BSE and NSE, fulfilling compliance requirements under SEBI regulations for the quarter ended March 31, 2026. The filing demonstrates the company's adherence to mandatory reporting obligations regarding its shareholding structure.

Regulatory Compliance Filing

The certificate was filed pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Nishu Kansal signed the submission on April 15, 2026, ensuring timely compliance with regulatory deadlines.

Shareholding Structure Confirmation

Alankit Assignments Limited, serving as the company's Registrar and Share Transfer Agent, provided the certificate confirming the shareholding status. The RTA's communication, signed by Manager Ramesh Khatau, contained specific details about the company's shareholder base during the reporting period.

Stock Exchange Submissions

The certificate was simultaneously submitted to both major Indian stock exchanges where Nureca's shares are listed. The company maintains its listing presence on both platforms, ensuring comprehensive regulatory compliance across all trading venues.

The BSE submission referenced scrip code 543264, while the NSE filing used scrip code NURECA. Both exchanges received identical documentation confirming the company's shareholding structure and compliance status for the quarter.

Corporate Information

Nureca Limited operates from its correspondence office in Chandigarh and registered office in Mumbai. The company maintains its corporate identification number L24304MH2016PLC320868 and continues its partnership with Alankit Assignments Limited for registrar and share transfer services.

This quarterly filing represents part of Nureca's ongoing regulatory obligations, ensuring transparency in its shareholding structure and maintaining compliance with SEBI's depositories and participants regulations.